Literature DB >> 17595763

Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.

Eleftherios Vairaktaris1, Giorgos Kalokerinos, Lambros Goutzanis, Sofia Spyridonidou, Stavros Vassiliou, Spyridoula Derka, Emeka Nkenke, Christos Yapijakis, Antonis Vylliotis, Andreas Lazaris, Efstratios Patsouris.   

Abstract

BACKGROUND: The expression of tumour suppressor p53 and oncogene c-myc was investigated in an experimental model of chemically induced carcinogenesis in normal and diabetic (type I) Sprague-Dawley rats.
MATERIALS AND METHODS: Tissue sections ranging from normal mucosa to moderately differentiated oral squamous cell carcinoma were studied using monoclonal antibodies against mutant p53 and c-myc proteins.
RESULTS: From hyperplasia to later stages of oral oncogenesis, mutant p53 expression was at higher levels in diabetic rats in comparison to normal animals, although the pattern of expression was similar. In contrast, c-myc expression was significantly higher in diabetic than in normal rats only in normal mucosa and hyperplasia.
CONCLUSION: It seems that diabetes contributed to increased accumulation of mutations in the p53 gene, contributing to increased proliferation of tumour cells during oral oncogenesis. Additionally, diabetes appeared to enhance c-myc expression only in the initial stages of oral oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595763

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Impact of hyperglycemia on the expression of GLUT1 during oral carcinogenesis in rats.

Authors:  Subhamita Dalal; Jayashree Adhikary; Anup Roy; Shampa Sarkar Biswas; Prabir Kumar Mukhopadhyay; Sagar Acharya; Amlan Ghosh
Journal:  Mol Biol Rep       Date:  2022-06-17       Impact factor: 2.742

2.  Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures.

Authors:  Melanie Cebioglu; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-11       Impact factor: 6.543

Review 3.  Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality.

Authors:  Pranay Ramteke; Ankita Deb; Varsha Shepal; Manoj Kumar Bhat
Journal:  Cancers (Basel)       Date:  2019-09-19       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.